Ireland's medical-device sector is globally significant, and its buyers are among the most careful in any market. Procurement leads, clinical advisors and health-system consultants research suppliers rigorously before any conversation begins, and increasingly the first filter in that research is an AI tool. For a medtech company, what AI says about you is now part of the procurement process whether you manage it or not.
How do medtech buyers research suppliers now?
Medtech buyers increasingly start with a question to an AI tool, and the shortlist begins forming there, long before any RFI or tender. The decision is still evidence-led, regulated and cautious, but the starting point has shifted. A procurement lead or clinical advisor will ask who makes this type of device, which specialist suppliers serve this procedure, or what the alternatives to an incumbent are. If you are not named, or named in the wrong terms, you are filtered out before the formal process starts.
Why are the stakes higher in medtech than in most sectors?
The stakes are higher because the cycle is long, the sector is compliance-sensitive and several stakeholders research independently.
- The cycle is long, so a wrong narrative compounds. A stale or inaccurate AI description does not brief one buyer once; it briefs a series of stakeholders over months, each forming an impression before you engage.
- It is compliance-sensitive, so accuracy is not optional. An AI tool repeating an out-of-date regulatory status, the wrong indications or a discontinued product line is not merely unhelpful in this sector: it can be disqualifying.
- Several stakeholders research independently. Procurement, clinical and technical reviewers may each consult AI. A consistent, correct narrative reinforces you across all of them; an inconsistent one fragments your case.
What is the most common AI visibility failure in medtech?
The most common and most damaging pattern in medtech is misclassification: being placed in the wrong category rather than being absent. A specialist device manufacturer described by AI as a general engineering firm is, for a procurement filter, effectively invisible to the right buyer. The company is present, even well described, but filed under a heading no clinical buyer would search. In device procurement, that does as much damage as being missing altogether. It is one of the four causes of a Gap: AI confused you with another kind of business.
In medtech the sales cycle is long enough for a wrong AI description to brief every stakeholder before you ever get to speak.
Why won't your own website fix this?
Your website will not fix it because medtech procurement, and the AI tools buyers use, trust independent corroboration above self-description. Regulatory listings, registries, clinical and industry references and distributor directories carry weight. If they are thin, outdated or describe an older portfolio, AI's view of you lags your actual capability, and updating your own site does not move them. The sources that shape the answer sit largely outside your domain, which is why the Gap is so easy to miss.
Does being in Ireland's medtech cluster help?
Yes. Because Ireland's medtech cluster is so concentrated, buyers and consultants researching Irish suppliers lean on a definable set of openly readable sources and bodies. Knowing which of those AI draws on for a given device category makes the diagnosis sharper, and the list of what to fix first more precise, than a generic, market-agnostic review could be.
What should a medtech company do first?
Measure first: see what AI says when a procurement lead or clinical advisor asks about your device category, whether it places you in the right category, and which competitor it recommends instead. A Genivista Gap Check shows that Gap at no charge, walked through with Neil. If the Gap is worth closing, a Gap Audit traces why and sets out what to fix first, and by whom.